CEVI — CellaVision AB Share Price

As of Today at 19:05 UTC, shares in CellaVision AB are trading at SEK221.50. This share price information is delayed by 15 minutes.

Shares in CellaVision AB last closed at SEK221.50 and the price had moved by +27.89% over the past 365 days. In terms of relative price strength the CellaVision AB share price has outperformed the FTSE Global All Cap Index by +17.96% over the past year.

The overall consensus recommendation for CellaVision AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.

The CellaVision AB dividend yield is 1.02% based on the trailing twelve month period.

Last year, CellaVision AB paid a total dividend of SEK2.25, and it currently has a trailing dividend yield of 1.02%.Looking ahead, shares in CellaVision AB are due to go ex-dividend on 2024-05-06 and the next dividend pay date is 2024-05-13.

CellaVision AB are due to go ex-dividend on 2024-05-06 and the next dividend pay date is 2024-05-13. The historic dividend yield on CellaVision AB shares is currently 1.02%.

To buy shares in CellaVision AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of SEK221.50, shares in CellaVision AB had a market capitalisation of SEK5.28bn.

Here are the trading details for CellaVision AB: 

• Country of listing: Sweden
• Exchange: STO
• Ticker Symbol: CEVI

Based on an overall assessment of its quality, value and momentum CellaVision AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

The analyst consensus target price for shares in CellaVision AB is SEK261.67.  That is 18.14% above the last closing price of SEK221.50.

Analysts covering CellaVision AB currently have a consensus Earnings Per Share (EPS) forecast of SEK7.28 for the next financial year.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like CellaVision AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +48.32%.

As of the last closing price of SEK221.50, shares in CellaVision AB were trading +13.91% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The CellaVision AB PE ratio based on its reported earnings over the past 12 months is 28.37. The shares last closed at SEK221.50. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

CellaVision AB's management team is headed by: 

• Soren Mellstig - NEC
• Simon Ostergaard - PRE
• Magnus Blixt - CFO
• Yve Van Thorenburg - VPR
• Peter Wilson - VPR
• Maria Morin - VPR
• Adam Morell - VPR
• Jeppe Brandstrup - VBD
• Julien Veyssy - OTH
• Christer Fahraeus - DRC
• Gunnar Hansen - DRC
• Markus Kristoffersson - DRC
• Asa Hedin - IND
• Anna Malm Bernsten - IND
• Niklas Prager - IND
• Juergen Riedl - IND
• Stefan Wolf - IND
• Mikael Worning - IND